Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Racial differences in glycemic markers: a cross-sectional analysis of community-based data.

Selvin E, Steffes MW, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL.

Ann Intern Med. 2011 Mar 1;154(5):303-9. doi: 10.7326/0003-4819-154-5-201103010-00004.

2.

Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies.

Ziemer DC, Kolm P, Weintraub WS, Vaccarino V, Rhee MK, Twombly JG, Narayan KM, Koch DD, Phillips LS.

Ann Intern Med. 2010 Jun 15;152(12):770-7. doi: 10.7326/0003-4819-152-12-201006150-00004.

PMID:
20547905
3.

Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose.

Juraschek SP, Steffes MW, Selvin E.

Clin Chem. 2012 Dec;58(12):1648-55. doi: 10.1373/clinchem.2012.188367. Epub 2012 Sep 27.

4.

Nontraditional markers of glycemia: associations with microvascular conditions.

Selvin E, Francis LM, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL, Steffes MW.

Diabetes Care. 2011 Apr;34(4):960-7. doi: 10.2337/dc10-1945. Epub 2011 Feb 18.

5.

Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay.

McGill JB, Cole TG, Nowatzke W, Houghton S, Ammirati EB, Gautille T, Sarno MJ; U.S. trial of the GlycoMark assay.

Diabetes Care. 2004 Aug;27(8):1859-65.

PMID:
15277408
6.

Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.

Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A.

Clin Biochem. 2007 Dec;40(18):1398-405. Epub 2007 Aug 10.

PMID:
17919531
7.

Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.

Konya J, Ng JM, Cox H, Cooke M, Lewis N, Bhandari S, Atkin SL, Kilpatrick ES.

Diabet Med. 2013 Oct;30(10):1250-4. doi: 10.1111/dme.12249. Epub 2013 Jul 9.

PMID:
23758176
8.

Does genetic ancestry explain higher values of glycated hemoglobin in African Americans?

Maruthur NM, Kao WH, Clark JM, Brancati FL, Cheng CY, Pankow JS, Selvin E.

Diabetes. 2011 Sep;60(9):2434-8. doi: 10.2337/db11-0319. Epub 2011 Jul 25.

9.

Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.

Parrinello CM, Selvin E.

Curr Diab Rep. 2014;14(11):548. doi: 10.1007/s11892-014-0548-3. Review.

10.
11.

Should the hemoglobin A1c diagnostic cutoff differ between blacks and whites? A cross-sectional study.

Tsugawa Y, Mukamal KJ, Davis RB, Taylor WC, Wee CC.

Ann Intern Med. 2012 Aug 7;157(3):153-9. doi: 10.7326/0003-4819-157-3-201208070-00004.

12.

Alternative markers of hyperglycemia and risk of diabetes.

Juraschek SP, Steffes MW, Miller ER 3rd, Selvin E.

Diabetes Care. 2012 Nov;35(11):2265-70. doi: 10.2337/dc12-0787. Epub 2012 Aug 8.

13.

Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes.

Herman WH, Dungan KM, Wolffenbuttel BH, Buse JB, Fahrbach JL, Jiang H, Martin S.

J Clin Endocrinol Metab. 2009 May;94(5):1689-94. doi: 10.1210/jc.2008-1940. Epub 2009 Mar 10.

PMID:
19276235
14.

Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study.

Heisler M, Faul JD, Hayward RA, Langa KM, Blaum C, Weir D.

Arch Intern Med. 2007 Sep 24;167(17):1853-60.

PMID:
17893306
15.

Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.

Emoto M, Tabata T, Inoue T, Nishizawa Y, Morii H.

Nephron. 1992;61(2):181-6.

PMID:
1630543
16.

Racial differences in glycemic control in a well-functioning older diabetic population: findings from the Health, Aging and Body Composition Study.

de Rekeneire N, Rooks RN, Simonsick EM, Shorr RI, Kuller LH, Schwartz AV, Harris TB; Health, Aging and Body Composition Study.

Diabetes Care. 2003 Jul;26(7):1986-92. Erratum in: Diabetes Care. 2003 Dec;26(12):3368.

PMID:
12832300
17.
18.

The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.

Beck R, Steffes M, Xing D, Ruedy K, Mauras N, Wilson DM, Kollman C; Diabetes Research in Children Network (DirecNet) Study Group.

Pediatr Diabetes. 2011 Dec;12(8):690-5. doi: 10.1111/j.1399-5448.2011.00764.x. Epub 2011 Apr 17.

19.

No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.

Godbout A, Hammana I, Potvin S, Mainville D, Rakel A, Berthiaume Y, Chiasson JL, Coderre L, Rabasa-Lhoret R.

Diabetes Metab. 2008 Dec;34(6 Pt 1):568-73. doi: 10.1016/j.diabet.2008.05.010. Epub 2008 Oct 14.

20.

Evaluation of serum biomarkers in nutritional disorders: glycated apolipoprotein B, fasting serum glucose, fructosamine, stable and labile glycated hemoglobin in diabetic and non-diabetic subjects.

De Michele G, Correale M, De Michele O, Guerra V, Mazzarelli R, Misciagna G.

Immunopharmacol Immunotoxicol. 2008;30(4):925-36. doi: 10.1080/08923970802337718 .

PMID:
18720163
Items per page

Supplemental Content

Write to the Help Desk